Table 1.
Advantages | Limitationsa |
---|---|
Proven efficacy for stroke prevention | Risk of bleeding complications |
Historical standard of care | Routine monitoring required |
Long half-life, once-daily dosing | Dose adjustments frequently needed |
Slow onset of action | |
Narrow therapeutic window | |
Dietary restrictions | |
Numerous drug interactions | |
Variability in patient response |
Note. From “New oral Xa and IIa inhibitors: updates and clinical trial results,” by S. Haas, 2008, J Thromb Thrombolysis, 25, p. 52–60. Copyright 2007, Springer Science+Business Media, LLC. Adapted with permission.
Some of the listed disadvantages may exist with other oral anticoagulants.